HealthStream

Digital Healthcare Trends Will Drive Integrated Workforce Management Transformation

AnalystConsensusTarget

Not Invested

Based on Analyst Price Targets

Published

24 Sep 24

Updated

01 May 25

n/a

AnalystConsensusTarget's Fair Value

n/a

-24.8%

-3.5%

-24.8%

-3.5%

You can edit this narrative until May 12 6:00 AM. Then, changes will post as Updates.

Author's Valuation

US$3428.6% undervalued

AnalystConsensusTarget Fair Value

Narrative

Updates8

Shared on 01 May 25

Fair value Decreased 1.05%

Shared on 23 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 17 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 09 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 02 Apr 25

Fair value Decreased 0.058%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 26 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 19 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 11 Mar 25

Fair value Decreased 0.35%

AnalystConsensusTarget has decreased revenue growth from 6.1% to 4.9% and increased future PE multiple from 51.8x to 59.1x.

AnalystConsensusTarget Fair Value

US$34

28.6% undervalued

Future estimation in

% p.a.

Decrease

Increase

Current revenue growth rate

4.18%

Healthtech revenue growth rate

10.78%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

Decrease

Increase

Current discount rate

8.26%

Calculation

US$23.26m

Earnings '28

49.53x

PE Ratio '28

US$1.15b

Market Cap '28

US$1.15b

Market Cap '28

27.44m

No. shares '28

US$41.99

Share Price '28

US$41.99 Share Price '28

Discounted to 2025 @ 7.86% p.a.

US$33.46

Fair Value '25